Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy—Boston, Massachusetts, 2016–2021

Abstract In our Boston-based outpatient parenteral antibiotic therapy (OPAT) program between 2016 and 2021, we found that a low proportion of patients with active hepatitis C virus (HCV) were prescribed HCV treatment by their OPAT provider and few achieved sustained virologic response. Clinicians sh...

Full description

Saved in:
Bibliographic Details
Published in:Open forum infectious diseases 2023-07, Vol.10 (7), p.ofad342-ofad342
Main Authors: Gupta, Akash, Ashour, Dina, Shebl, Fatma M, Platt, Laura, Chiosi, John J, Nelson, Sandra B, Ard, Kevin L, Kim, Arthur Y, Bassett, Ingrid V
Format: Article
Language:English
Subjects:
Brief Report
Drug therapy
Hepatitis C virus
Infection
Patient outcomes
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract In our Boston-based outpatient parenteral antibiotic therapy (OPAT) program between 2016 and 2021, we found that a low proportion of patients with active hepatitis C virus (HCV) were prescribed HCV treatment by their OPAT provider and few achieved sustained virologic response. Clinicians should consider concurrent HCV treatment during OPAT.
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofad342